BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 29784618)

  • 1. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
    Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
    Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
    Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
    Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
    Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
    Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
    Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
    Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
    Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oocyte accumulation for fertility preservation in women with benign ovarian tumours with a history of previous surgery, multiple or large cysts.
    Legrand C; Keller L; Collinet P; Barbotin AL; Béhal H; Rubod C; Decanter C
    Reprod Biomed Online; 2021 Aug; 43(2):205-214. PubMed ID: 34247989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
    Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
    Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oocyte cryopreservation for fertility preservation in women with ovarian endometriosis.
    Kim SJ; Kim SK; Lee JR; Suh CS; Kim SH
    Reprod Biomed Online; 2020 Jun; 40(6):827-834. PubMed ID: 32295746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
    Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
    Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls.
    Decanter C; Robin G; Mailliez A; Sigala J; Morschhauser F; Ramdane N; Devos P; Dewailly D; Leroy-Martin B; Keller L
    Reprod Biomed Online; 2018 May; 36(5):543-551. PubMed ID: 29506861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should we perform oocyte accumulation to preserve fertility in women with Turner syndrome? A multicenter study and systematic review of the literature.
    Brouillet S; Ranisavljevic N; Sonigo C; Haquet E; Bringer-Deutsch S; Loup-Cabaniols V; Hamamah S; Willems M; Anahory T
    Hum Reprod; 2023 Sep; 38(9):1733-1745. PubMed ID: 37381072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to ovarian stimulation in patients facing gonadotoxic therapy.
    Johnson LN; Dillon KE; Sammel MD; Efymow BL; Mainigi MA; Dokras A; Gracia CR
    Reprod Biomed Online; 2013 Apr; 26(4):337-44. PubMed ID: 23415997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of ovarian stimulation for oocyte cryopreservation in women with Turner syndrome.
    Talaulikar VS; Conway GS; Pimblett A; Davies MC
    Fertil Steril; 2019 Mar; 111(3):505-509. PubMed ID: 30598170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
    Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
    Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian response to stimulation for fertility preservation in women with hematologic cancer.
    Brun T; Dion L; Jaillard S; Bales D; Domin M; Lavoué V; Levêque J; Houot R; Duros S
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101925. PubMed ID: 33010467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
    Alvarez RM; Ramanathan P
    Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
    Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of ovarian stimulation after treatment with chemotherapy.
    Chan JL; Johnson LN; Efymow BL; Sammel MD; Gracia CR
    J Assist Reprod Genet; 2015 Oct; 32(10):1537-45. PubMed ID: 26400507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.
    Sonigo C; Comtet M; Duros S; Sifer C; Sermondade N; Grynberg M
    J Assist Reprod Genet; 2018 Jan; 35(1):91-97. PubMed ID: 28986734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.